Ocular Therapeutix (OCUL) EBIT Margin Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 3,609.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1,536.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -170.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -3,724.00
10 Ocular Therapeutix 1.99 Bn 1.99 Bn 9.46 Mn -26,799.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -26,799.00
Dec 31, 2025 -23,041.00
Sep 30, 2025 -17,414.00
Jun 30, 2025 -23,744.00
Mar 31, 2025 -38,346.00
Dec 31, 2024 -16,061.00
Sep 30, 2024 -17,080.00
Jun 30, 2024 -12,968.00
Mar 31, 2024 -4,540.00
Dec 31, 2023 209.00
Sep 30, 2023 5,265.00
Jun 30, 2023 2,691.00
Mar 31, 2023 -3,337.00
Dec 31, 2022 909.00
Sep 30, 2022 -1,937.00
Jun 30, 2022 1,028.00
Mar 31, 2022 14,028.00
Dec 31, 2021 4,852.00
Sep 30, 2021 7,767.00
Jun 30, 2021 96,719.00
Mar 31, 2021 36,128.00
Dec 31, 2020 75,346.00
Sep 30, 2020 255,344.00
Jun 30, 2020 218,309.00
Mar 31, 2020 335,873.00
Dec 31, 2019 248,054.00
Sep 30, 2019 18,330.00
Jun 30, 2019 -122,971.00
Mar 31, 2019 -3,818.00
Dec 31, 2018 -81,808.00
Sep 30, 2018 -6,956.00
Jun 30, 2018 209,378.00
Mar 31, 2018 -65,798.00
Dec 31, 2017 -17,038.00
Sep 30, 2017 -96,886.00
Jun 30, 2017 -166,839.00
Mar 31, 2017 -77,317.00
Dec 31, 2016 16,716.00
Sep 30, 2016 2.53 Mn
Jun 30, 2016 -41,947.00
Mar 31, 2016 46,245.00
Dec 31, 2015 -111,341.00
Sep 30, 2015 -2.25 Mn
Jun 30, 2015 403,077.00
Mar 31, 2015 2.23 Mn